Midday Market Update: Economic Data Pauses Stocks, ETFs
October 20, 2009 – Stocks and exchange traded funds (ETFs) dipped lower this morning after a slew of economic reports left investors jittery about the economy. Some positive earnings reports softened the blow, however. (more…) Continue Reading »

Midday Market Update: Stocks, ETFs Slip Following Earnings
October 13, 2009 – Stocks and exchange traded funds (ETFs) went negative after some early earnings reports left investors feeling a little cold. Many on Wall Street sought solace in gold, which has hit a new record high. (more…) Continue Reading »

How the Race for a Cancer Drug Could Help Pharmaceutical ETFs
September 7, 2009 – Billions of dollars are being poured into cancer-fighting drugs. But it’s not just to find a cure – it’s also to gain market share in one of the most untapped markets, from a pharmaceutical... Continue Reading »

Pharmaceuticals: How Obama Deal and New Approach Could Refresh ETFs
June 22, 2009 – The pharmaceutical industry and exchange traded funds are poised for some big changes as President Barack Obama closes loopholes and drug companies change drug development tactics. (more…) Continue Reading »

Why Merger of Giants Could Help Pharmaceutical ETFs
January 26, 2009 – What is a beaten-down global drug industry that has been hit by flagging product development and high fixed costs doing to restructure and regain strength and  what effect will this have on exchange traded funds (ETFs)? ... Continue Reading »

4 Reasons to Watch Pharmaceutical ETFs This Year
January 9, 2009 – One of the best performing stock-based exchange traded fund (ETF) segments for the year 2008 was pharmaceuticals, a sub-segment of the health care industry, and there are brighter prospects for the sector in 2009. (more…) Continue Reading »

Pharma, ETFs Give in to Emerging Markets Lure
November 18, 2008 – Along with the broader economy, the pharmaceuticals industry and exchange traded funds (ETFs) are falling on hard times. Some patients have stopped taking their drugs – even the necessary ones – which could damage the... Continue Reading »

Pharmaceutical ETFs Ailing as Consumers Trim Costs
October 22, 2008 – Exchange traded funds (ETFs) targeting the pharmaceutical sector can’t seem to win: some companies are getting dinged by a consumer rush to generics, while others are getting hit because some people don’t want to shell... Continue Reading »

Healthcare ETFs Are Pulsing Amid Dire Conditions
September 4, 2008 – Health care and related exchange traded funds (ETFs) have remained on a steady beat while the rest of the market has faced challenges. With the coming election in November, everyone’s wondering what will become of healthcare... Continue Reading »

Success Of Cancer Vaccines Could Have Pharm ETFs Feeling Good
August 23, 2008 – With drug makers making a push for cervical cancer vaccination, the industry is quickly growing and certain ETFs can capture this growth. In a New York Times article, Elisabeth Rosenthal examines how over the past two... Continue Reading »